Yassine Bentefour1, Mohamed Bennis1, René Garcia2, Saadia Ba M'hamed1. 1. Laboratoire de Pharmacologie, Neurobiologie et Comportement, Centre National de la Recherche Scientifique et Technique, URAC 37, Cadi Ayyad Université, Marrakech, Maroco. 2. Institut de Neurosciences de la Timone, UMR7289, Aix-Marseille Université and Centre National de la Recherche Scientifique, 13385, Marseille, France. rene.garcia@unice.fr.
Abstract
RATIONALE: After exposure to a severe traumatic event, avoidance, fear sensitization, and increased anxiety are among features that can persist over time in people developing posttraumatic stress disorder (PTSD). Basic research on treatment interfering with these symptoms can provide insights to improve PTSD treatment. OBJECTIVES: The purposes of the present study were to induce these behavioral changes in mice and examine whether paroxetine would interfere with their expression. METHODS: Mice were submitted to avoidance training with a low (0.4 mA) or high (1.5 mA) foot-shock intensity, as mild and severe stressors, respectively, and posttraining avoidance was evaluated 1 and 12 days later. Fear sensitization, measured as increased freezing to a neutral tone, and enhanced contextual fear, measured as increased freezing to a conditioned context (wherein all mice received a 0.4-mA foot-shock), were assessed during this time window. An elevated plus maze test was also used to assess mouse anxiety-like behavior. RESULTS: Persistent avoidance, persistent fear sensitization, and long-term enhancement of contextual fear and increased anxiety-like behavior were established only in mice that received the 1.5-mA foot-shock during avoidance training. Paroxetine (at 8 mg/kg/day), injected from day 5 to day 11 after avoidance training, suppressed all of these behavioral changes. CONCLUSIONS: These data provide additional evidence for the role of paroxetine against expression of PTSD-like behaviors in mice.
RATIONALE: After exposure to a severe traumatic event, avoidance, fear sensitization, and increased anxiety are among features that can persist over time in people developing posttraumatic stress disorder (PTSD). Basic research on treatment interfering with these symptoms can provide insights to improve PTSD treatment. OBJECTIVES: The purposes of the present study were to induce these behavioral changes in mice and examine whether paroxetine would interfere with their expression. METHODS:Mice were submitted to avoidance training with a low (0.4 mA) or high (1.5 mA) foot-shock intensity, as mild and severe stressors, respectively, and posttraining avoidance was evaluated 1 and 12 days later. Fear sensitization, measured as increased freezing to a neutral tone, and enhanced contextual fear, measured as increased freezing to a conditioned context (wherein all mice received a 0.4-mA foot-shock), were assessed during this time window. An elevated plus maze test was also used to assess mouseanxiety-like behavior. RESULTS: Persistent avoidance, persistent fear sensitization, and long-term enhancement of contextual fear and increased anxiety-like behavior were established only in mice that received the 1.5-mA foot-shock during avoidance training. Paroxetine (at 8 mg/kg/day), injected from day 5 to day 11 after avoidance training, suppressed all of these behavioral changes. CONCLUSIONS: These data provide additional evidence for the role of paroxetine against expression of PTSD-like behaviors in mice.
Entities:
Keywords:
Animal model of PTSD symptoms; Antidepressant; Fear sensitization; Passive avoidance
Authors: Christoph K Thoeringer; Kathrin Henes; Matthias Eder; Maik Dahlhoff; Wolfgang Wurst; Florian Holsboer; Jan M Deussing; Sven Moosmang; Carsten T Wotjak Journal: Neuropsychopharmacology Date: 2011-10-26 Impact factor: 7.853
Authors: W Victor R Vieweg; Demetrios A Julius; Antony Fernandez; Mary Beatty-Brooks; John M Hettema; Anand K Pandurangi Journal: Am J Med Date: 2006-05 Impact factor: 4.965